Enriqueta Felip
Author
Institution Vall d'Hebron Hospital Universitari
Past institutions Vall d'Hebron Institute of Oncology, Vall d'Hebron Hospital Universitari, Dana-Farber Cancer Institute, Universitat Autònoma de Barcelona, Hebron University +5 more
ORCID: Yes
H-index: 118
I10-index: 514
Works count: 1,402
Citations count: 96,230
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
2015 · H. Borghaei, L. Paz-Ares, et al. · New England Journal of Medicine
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2015 · Roy S. Herbst, Paul Baas, et al. · The Lancet
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
2015 · Edward B. Garon, Naiyer A. Rizvi, et al. · New England Journal of Medicine